1 | frfr gbgb hrhr ieie | | | | | | | 4 | 0.34% |
2 | nono pepe plpl pypy | | | | | | | 4 | 0.34% |
3 | eses fifi frfr gbgb | | | | | | | 4 | 0.34% |
4 | dkdk eses fifi frfr | | | | | | | 4 | 0.34% |
5 | dede dkdk eses fifi | | | | | | | 4 | 0.34% |
6 | crcr dede dkdk eses | | | | | | | 4 | 0.34% |
7 | coco crcr dede dkdk | | | | | | | 4 | 0.34% |
8 | chch coco crcr dede | | | | | | | 4 | 0.34% |
9 | caca chch coco crcr | | | | | | | 4 | 0.34% |
10 | mxmx nlnl nono pepe | | | | | | | 4 | 0.34% |
11 | nlnl nono pepe plpl | | | | | | | 4 | 0.34% |
12 | fifi frfr gbgb hrhr | | | | | | | 4 | 0.34% |
13 | pepe plpl pypy sese | | | | | | | 4 | 0.34% |
14 | plpl pypy sese sisi | | | | | | | 4 | 0.34% |
15 | be leaving this country | | | | | | | 3 | 0.25% |
16 | which may have different | | | | | | | 3 | 0.25% |
17 | flag you will be | | | | | | | 3 | 0.25% |
18 | krkr mxmx nlnl nono | | | | | | | 3 | 0.25% |
19 | you will be leaving | | | | | | | 3 | 0.25% |
20 | will be leaving this | | | | | | | 3 | 0.25% |
21 | pypy sese sisi usus | | | | | | | 3 | 0.25% |
22 | sese sisi usus uyuy | | | | | | | 3 | 0.25% |
23 | in the dechra group | | | | | | | 3 | 0.25% |
24 | another site in the | | | | | | | 3 | 0.25% |
25 | site in the dechra | | | | | | | 3 | 0.25% |
26 | group not applicable to | | | | | | | 3 | 0.25% |
27 | dechra group not applicable | | | | | | | 3 | 0.25% |
28 | may have different legislation | | | | | | | 3 | 0.25% |
29 | the dechra group not | | | | | | | 3 | 0.25% |
30 | sisi usus uyuy veve | | | | | | | 3 | 0.25% |
31 | a flag you will | | | | | | | 3 | 0.25% |
32 | cushing keyboardarrowdown cushings webinar | | | | | | | 3 | 0.25% |
33 | international veterinary pharmaceuticals and | | | | | | | 3 | 0.25% |
34 | veterinary pharmaceuticals and related | | | | | | | 3 | 0.25% |
35 | pharmaceuticals and related products | | | | | | | 3 | 0.25% |
36 | brbr caca chch coco | | | | | | | 3 | 0.25% |
37 | and related products business | | | | | | | 3 | 0.25% |
38 | clicking a flag you | | | | | | | 3 | 0.25% |
39 | keyboardarrowdown webinar de apresentação | | | | | | | 2 | 0.17% |
40 | keyboardarrowdown eutanásia keyboardarrowdown antibióticos | | | | | | | 2 | 0.17% |